Target intelligence / Profile preview

ZBTB20 antisense RNA 4 (ZBTB20-AS4)

Target
ZBTB20-AS4
Molecular classification
Long non-coding RNA, lncRNA
01

Overview

ZBTB20 antisense RNA 4 (ZBTB20-AS4) is a long non-coding RNA transcribed in antisense orientation to the ZBTB20 gene. While ZBTB20 itself encodes a transcription factor involved in differentiation, immunity, and liver development[1][2][4], ZBTB20-AS4 does not encode any protein and has no experimentally validated molecular function, disease relevance, or therapeutic targeting information reported to date. Its annotation as a non-protein coding antisense transcript is current, but its biological significance remains undefined[3]. ZBTB20-AS4 is distinct from the protein-coding gene ZBTB20, which has recognized roles such as transcriptional repression in immune and developmental pathways[1][2][4]. ZBTB20-AS4’s lack of functional characterization means it is not considered a canonical therapeutic target, biomarker, or drug-interaction partner at present. This assessment is based on current molecule and gene catalog listings, as well as absence of functional or disease-related data in major molecular biology references[3].

Other names
ZBTB20-AS4ZBTB20 antisense RNA 4 (non-protein coding)
02

Biological functions

No experimentally established biological function is currently attributed to ZBTB20-AS4. ZBTB20, the protein-coding gene, is involved in differentiation, immunity, and development[1][2][4], but ZBTB20-AS4’s function is unknown.
03

Disease associations

No established disease association or disease mechanism reported for ZBTB20-AS4 as of now.

Beyond the preview

Go deeper on ZBTB20 antisense RNA 4 (ZBTB20-AS4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ZBTB20 antisense RNA 4 (ZBTB20-AS4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call